November 2021 – Page 5 – Somalia News Gazette

November 29, 2021

UnionPay International partners with M2M to drive digital transformation in Africa

CASABLANCA, Morocco, Nov. 29, 2021 /PRNewswire/ — UnionPay International (UPI) and M2M jointly announced a partnership to accelerate digital financial transformation in Africa, creating new frontiers by leveraging two entities’ strong core capabilities and footprints.

This partnership sets an ambitious product roadmap that allows M2M to provide innovative and customer-centric payment solutions to support issuers, acquirers, fintechs, processors and aggregators across more than 40 countries worldwide.

“Becoming UPI’s certified Third Party Service Provider (TPSP) is a major milestone underscoring our drive to be a one-stop shop and a service payment platform that truly offer clients solutions covering the entire value chain of payments including issuing, acquiring and processing of expanding UPI’s transactions worldwide”, said Mr Rachid SAIHI, CEO of M2M Group. “Thanks to this partnership, M2M Group will be among the first payments actors in Africa to provide end to end processing solutions for UPI’s transactions”.

“We are delighted to collaborate with M2M to facilitate the digital financial transformation in Africa”, said Mr Luping Zhang, General Manager of Africa Branch, UnionPay International. ” UnionPay International continues to offer high quality, cost-effective, innovative payment services through shared growth in the region and contribute value towards the global payment ecosystem”.

At the forefront of the digital era, M2M Group leverages more than 30 years of worldwide innovation and expertise. M2M Group is a leading software company that provides multichannel electronic payments and eGov solutions and services that enable convenience and trust for anyone, anywhere, anytime, and any device. M2M Group’s solutions address a wide range of applications accelerating digital convergence, enhancing user experience and boosting business agility and profitability. M2M Group is listed on Casablanca’s Stock Exchange.

With over 160 million UnionPay cards issued outside of mainland China, UnionPay has expanded its acceptance network to 180 countries and regions in recent years. At present, UnionPay cards are widely accepted in Africa across all sectors, effectively meeting the diverse purchasing needs of UnionPay cardholders visiting and living on the continent. Over 10 African countries have issued UnionPay cards, including Kenya, Tanzania, Uganda, Ghana, South Africa, eSwatini, Madagascar and Mauritius. The Nilson Report (Issue 1154) shows that UnionPay ranks first among all card schemes in card issuance and transaction volume. UnionPay has launched various innovative payment products in Africa in response to the worldwide digital transformation and financial inclusion.

November 29, 2021

Joy Spreader Announces Unaudited Results for the First Three Quarters of 2021, with Revenue up 61.1% YoY to HK$945 million

BEIJING, Nov. 29, 2021 /PRNewswire/ — On November 29, Hong Kong-listed Joy Spreader Group Inc. (“Joy Spreader” or the “Company”, Stock Code: 06988.HK) announced its results for the first three quarters of 2021. From January to September, Joy Spreader achieved revenue of HK$945 million (approx. US$121 million), up 61.1% YoY. Gross profit reached HK$331 million, up 94.5% YoY, while gross margin improved to 35.1%, up from 29.1% in the same period of 2020.

The operating results show that Joy Spreader’s short video e-commerce marketing business continued growing at a rapid rate. From January to September of this year, the business posted gross merchandise value (GMV) of HK$897 million, 3.5 times that of the same period of last year; while revenue hiked to HK$194 million, a 4-fold improvement. Interactive entertainment and other digital product marketing businesses grew steadily, with turnover for the reporting period reaching HK$2.712 billion, up 108.3% YoY, while revenue climbed to HK$750 million, up 39.9% YoY.

Since listing in Hong Kong in September 2020, Joy Spreader’s performance has maintained substantial growth for five consecutive quarters, with continuous improvement in revenue and profitability, both indicators demonstrating strong stability and sustainability.

For more information about Joy Spreader Group Inc., please visit here.

تشينغداو: مدينة مفعمة بالشباب والحيوية

QINGDAO, China, 29 نوفمبر / تشرين ثاني 2021 /PRNewswire/ —

تقع مدينة تشينغداو في الطرف الجنوبي لشبه جزيرة شاندونغ، وهي مدينة ساحلية مفتوحة في شمالي الصين تتمتع بالسحر الإنساني وتفوقات الموارد الطبيعية. تُعتبر مدينة ميناء دولية ومدينة تاريخية وثقافية مشهورة في الصين. تبلغ مساحتها البرية 11 ألف كيلومتر مربع، ومساحتها البحرية 12 ألف كيلومتر مربع، ولها سلطة على سبعة أحياء وثلاث مدن على مستوى المحافظة، ويبلغ عدد سكانها الدائمين 106ر10 ملايين نسمة. وفي هذه المدينة، لا برد قارس في الشتاء ولا حرارة شديدة في الصيف، بل تكون مصيفا مشهورا فازت بجائزة البيئة المناسبة للإسكان في الصين ولقب “أكثر مدن صينية تتمتع بالقوة التنافسية البيولوجية لعام 2019”.

نجحت تشينغداو في استضافة مسابقات القوارب الشراعية لدورة الألعاب الأولمبية الصيفية لعام 2008 والمعرض الدولي للبستنة لعام 2014 ومنتدى الصحة العالمي في منتدى بوآو الآسيوي وقمة تشينغداو لقادة الشركات المتعددة الجنسيات ومؤتمر رأس المال الاستثماري العالمي (تشينغداو) وندوة تشينغداو للتفاعل البري والبحري لعام 2020 وقمة يابولي الصيفي لمنتدى رجال الأعمال الصينيين ومنتدى تشينغداو لقمة رجال الأعمال للصين والاتحاد الأوربي والمؤتمر العالمي لصناعة الإنترنت الصناعي وغيرها من أنشطة المؤتمرات والمعارض الهامة. حظيت الاستضافة الناجحة لقمة تشينغداو لمنظمة شانغهاي للتعاون لعام 2018 بثناء عال من الضيوف الحاضرين من مختلف الدول. علاوة على ذلك، تكون تشينغداو مدينة مشهورة بكرة القدم ومدينة السينما والتلفزيون ومدينة الموضة ومدينة القوارب الشراعية، وحصلت على “المدينة المتحضرة في البلاد” و”المدينة الصيحية الوطنية” و”أفضل عشر مدن للحياة السعيدة في الصين” و”أسعد مدينة في الصين لعام 2020″ وغيرها من سلسلة من الألقاب الفخرية.

تُعد تشينغداو من نقاط المواصلات الرئيسية على الممر الاقتصادي للجسر البري الأوراسي الجديد ونقاط الارتكاز للتعاون البحري، وتتميز بقيمة “النقطة المزدوجة” الفريدة في تشكيل نمط التنمية الجديدة، وتحمل بناء المنطقة النموذجية للتعاون الاقتصادي والتجاري المحلي للصين ومنظمة شانغهاي للتعاون ومنطقة تشينغداو لمنطقة التجارة الحرة التجريبية بمقاطعة شاندونغ وغير ذلك من المهام الإستراتيجية الوطنية، وتعمل على بناء منصة جديدة للتعاون الدولي لـ”الحزام والطريق”. وفي تشينغداو المنطقة الجديدة في الساحل الغربي ووادي لانقو ومنطقة التكنولوجيا العالية والمنطقة الاقتصادية الجوية النموذجية في جياودونغ وغيرها من عديد من مناطق الوظائف على المستوى الوطني، وقد نشأت فيها هاير وهايسنس وبيرة تشينغداو وشركة سيفانغ للقاطرات والعربات بتشينغداو التابعة لمجموعة CRRC وغيرها من الشركات الصينية المشهورة وشركة جيهوا البيولوجية وشركة ريريتشون لنقل وتوزيع البضائع وشركة جيوهاوكان للتكنولوجيا ومجموعة ويدونغيون للتعليم ومنصة كوسمو للإنترنت الصناعية وشركة تلايديان لشحن السيارات الكهربائية ومجموعة ننغليان لشبكة صناعة الطاقة وغيرها من الشركات الناشئة والرائدة والواعدة. وتتمتع تشينغداو بقدرة قوية على البحث العلمي البحري، حيث بنت المختبر البحري التجريبي الوطني بتشينغداو والقاعدة البحرية لأعماق البحر ومركز الابتكار التقني الوطني للقطار الفائق السرعة وغيرها من مختلف المنصات الابتكارية الوطنية.

في الأرباع الثلاثة الأولى من عام 2021، حققت تشينغداو قيمة الصادرات والواردات الإجمالية البالغة 59ر622 مليار يوان، بزيادة 6ر36% عما كان عليه في نفس الوقت من العام الماضي. وبالتالي، ستنفذ مدينة تشينغداو مفاهيم التنمية الجديدة وتسرع في بناء مدينة دولية حديثة مفعمة بالحيوية وغنية بالقدرة ومميزة بالسحر الفريد.

Photo – https://mma.prnewswire.com/media/1697827/Qingdao_Bay.jpg
Photo – https://mma.prnewswire.com/media/1697829/Qingdao_Olympic_Sailing_Center.jpg
Logo – https://mma.prnewswire.com/media/1245709/Qingdao_Logo.jpg

مسؤول الاتصال: تشو يي لينغ

الهاتف: 85911619-532-0086

الموقع الإلكتروني: http://www.qingdaochina.org

فيسبوك: https://www.facebook.com/qingdaocity

تويتر: https://twitter.com/loveqingdao

November 29, 2021

Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, Omicron, Are Associated with Escape from ADG20 Neutralization In Vitro

Additional in vitro studies to determine neutralization activity of ADG20 against Omicron are ongoing

ADG20 EUA submissions planned for prevention and treatment of COVID-19 in mid-2022

Inventory build continues in anticipation of EUA in second half of 2022, with 4 million doses available for distribution over the next two years

WALTHAM, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today provided information related to the potential of its lead SARS-CoV-2 antibody, ADG20, to address the Omicron SARS-CoV-2 variant, and other known variants of concern. ADG20 is an investigational monoclonal antibody (mAb) product candidate designed to provide broad and potent neutralizing activity against SARS-CoV-2, including variants of concern, for the prevention and treatment of COVID-19 with potential duration of protection for up to one year in a single injection.

“The continued global scale of the COVID-19 pandemic has led to increased levels of immune pressure on the virus, which is driving the emergence of variants containing mutations associated with escape from common classes of neutralizing antibodies induced by natural infection or vaccination. Unlike most antibodies currently available under EUA, ADG20 has been shown to target an epitope that is highly conserved among clade I sarbecoviruses and that is not readily targeted by the endogenous neutralizing antibody response,” said Laura Walker, Ph.D., co-founder and chief scientific officer of Adagio. “Due to the highly conserved and immunorecessive nature of the epitope recognized by ADG20, we expect that ADG20 will retain activity against Omicron, as we have observed in in vitro models with all other variants of concern identified previously. Further, none of the mutations present in the spike protein of the Omicron variant have been associated with escape from ADG20 neutralization. ADG20 was engineered for potent and broadly neutralizing activity in anticipation of both the rapid antigenic evolution of SARS-CoV-2 and the emergence of future SARS-like viruses with pandemic potential.”

“ADG20 was uniquely designed to combine breadth, potency and duration of protection against SARS-CoV-2 for up to one year in a single injection. We did this anticipating that SARS-CoV-2 would continue to evolve and potentially render some early therapies and vaccines obsolete,” said Tillman Gerngross, Ph.D., co-founder and chief executive officer of Adagio. “Our global clinical trials are advancing with potential EUA submissions in mid-2022 for both prevention and treatment of COVID-19. We continue to engage with the FDA and other regulatory bodies and governmental agencies to discuss potential acceleration of development plans and the need for a portfolio of therapeutic solutions to combat the COVID-19 pandemic.”

Given the significant potential health crisis resulting from the emergence of Omicron, Adagio is undertaking a number of activities to support ADG20’s utility in addressing this newly emerged variant of concern, including:

Conducting in vitro studies to evaluate the expected binding and neutralizing activity of ADG20 against Omicron. Initial data from these studies is anticipated by the end of the year; and
Recruiting patients in Adagio’s Phase 2/3 COVID-19 treatment trial, known as STAMP, across several clinical sites in South Africa (along with ongoing clinical trial efforts globally) in an effort to generate clinical data for ADG20 against infections due to the Omicron variant.

Based on the data being generated, Adagio plans to engage with health authorities and government agencies to accelerate development and supply of ADG20 to combat SARS-CoV-2 and its variants of concern.

ADG20 and Variants of Concern
The neutralizing antibody response induced by SARS-CoV-2 infection and vaccination is dominated by three classes of receptor binding domain (RBD)-directed antibodies (Class 1, Class 2 and Class 3), which often share common escape mutations. The newly emerged Omicron (B.1.1.529) variant identified in South Africa contains mutations associated with resistance to a large proportion of these commonly elicited antibodies, which may be due to immune pressure on these antigenic sites. Data for most antibodies available under EUA or in late-stage clinical development show they target one of these three dominant antigenic regions within the RBD.

In vitro studies have shown that ADG20 binds to a highly conserved epitope within the RBD that is not targeted by any of the common classes of neutralizing antibodies induced by SARS-CoV-2 infection and vaccination. Thus, unlike many other clinical-stage antibodies, which were isolated from COVID-19 patients and recognize epitopes that are also targeted by endogenous neutralizing antibodies, there is limited immune pressure on the ADG20 binding site. The ADG20 epitope has remained conserved in 99.99% of the nearly 4 million full length SARS-CoV-2 viral sequences deposited in the GISAID database as of October 15, 2021, and, as shown in in vitro studies, ADG20 retains activity against prior variants of concern including Alpha, Beta, Delta, and Gamma. For the Omicron variant, none of the mutations present in the spike protein are associated with escape from ADG20 neutralization. Based on published epitope mapping and structural studies, Adagio anticipates that ADG20 will retain neutralizing activity against the Omicron variant whereas other mAb products may lose substantial activity against this variant.

Previously disclosed in vitro data demonstrated retained neutralizing activity of ADG20 against a diverse panel of circulating SARS-CoV-2 variants, including the recently emerged Lambda, Mu and Delta plus variants. Notably, findings from these in vitro studies showed that ADG20 demonstrated potent neutralizing activity against all SARS-CoV-2 variants of concern tested, including those with reduced susceptibility to mAb products currently available under EUA or in late-stage development.

About ADG20
ADG20, an investigational monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is advancing through global clinical trials for the prevention and treatment of COVID-19, the disease caused by SARS-CoV-2. ADG20 was designed and engineered to possess high potency and broad neutralization activity against SARS-CoV-2 and additional clade 1 sarbecoviruses by targeting a highly conserved epitope in the receptor binding domain. ADG20 was further engineered to provide an extended half-life for durable protection. ADG20 has demonstrated potent neutralizing activity against the original SARS-CoV-2 virus, SARS-CoV-2 variants of concern Alpha, Beta, Delta, and Gamma, other SARS-CoV-2 variants to date, and additional SARS-like viruses in preclinical studies. ADG20 is administered in clinical trials by a single intramuscular injection. To date, ADG20 has been well-tolerated in a Phase 1 trial with no safety signals identified through a minimum of three months follow-up across all cohorts. ADG20 has not been approved for use in any country, and safety and efficacy have not yet been established.

About Adagio Therapeutics
Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, including COVID-19 and influenza. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with the potential for a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple non-competing, broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with third-party contract manufacturers to support the completion of clinical trials and initial commercial launch, ensuring the potential for broad accessibility to people around the world. For more information, please visit www.adagiotx.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates,” “believes,” “expects,” “intends,” “projects,” and “future” or similar expressions are intended to identify forward-looking statements. Forward-looking statements include statements concerning, among other things, the timing, progress and results of our preclinical studies and clinical trials of ADG20, including the timing of our planned EUA submissions, initiation, modification and completion of studies or trials and related preparatory work, the period during which the results of the trials will become available and our research and development programs; the expected neutralizing activity of ADG20 against the Omicron variant; our ability to obtain and maintain regulatory approvals for, our product candidates; our ability to identify patients, including in specific populations, with the diseases treated by our product candidates and to enroll these patients in our clinical trials; our expectations regarding the scope of any approved indication for ADG20; and the risk/benefit profile of our product candidates to patients; our manufacturing capabilities and strategy, including plans for doses available in the near future; and our ability to successfully commercialize our product candidates. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from the results described in or implied by the forward-looking statements, including, without limitation, the impacts of the COVID-19 pandemic on our business, clinical trials and financial position, unexpected safety or efficacy data observed during preclinical studies or clinical trials, clinical trial site activation or enrollment rates that are lower than expected, changes in expected or existing competition, changes in the regulatory environment, and the uncertainties and timing of the regulatory approval process. Other factors that may cause our actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are described under the heading “Risk Factors” in Adagio’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 and in Adagio’s future reports to be filed with the SEC, including Adagio’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021. Such risks may be amplified by the impacts of the COVID-19 pandemic. Forward-looking statements contained in this press release are made as of this date, and Adagio undertakes no duty to update such information except as required under applicable law.

Contacts:
Media Contact:
Dan Budwick, 1AB
Dan@1abmedia.com

Investor Contact:
Monique Allaire, THRUST Strategic Communications
monique@thrustsc.com

November 29, 2021

US Stocks Sink on New COVID Variant; Dow Loses 905 Points

NEW YORK — Stocks sank Friday, with the Dow Jones Industrial Average briefly falling more than 1,000 points, as a new coronavirus variant first detected in South Africa appeared to be spreading across the globe. Investors were uncertain whether the variant could reverse months of progress at getting the COVID-19 pandemic under control.

The S&P 500 index dropped 106.84 points, or 2.3%, to close at 4,594.62. It was the worst day for Wall Street’s benchmark index since February.

The index was dragged lower by banks, travel companies and energy companies as investors tried to reposition to protect themselves financially from the new variant. The World Health Organization called the variant “highly transmissible.”

The price of oil fell about 13%, the biggest decline since early in the pandemic, amid worries of another slowdown in the global economy. That in turn dragged down energy stocks. Exxon shares fell 3.5% while Chevron fell 2.3%.

The blue chips closed down 905.04 points to end the day at 34,899.34. The Nasdaq Composite lost 353.57 points, or 2.2%, to 15,491.66.

Bond yields fall; banks hit

“Investors are likely to shoot first and ask questions later until more is known,” Jeffrey Halley of Oanda said in a report. That was evident from the action in the bond market, where the yield on the 10-year Treasury note fell to 1.48% from 1.64% on Wednesday. As a result, banks took some of the heaviest losses. JPMorgan Chase dropped 3%.

There have been other variants of the coronavirus — the delta variant devastated much of the U.S. throughout the summer — and investors, public officials and the general public are jittery about any new variant that’s spreading. It’s been nearly two years since COVID-19 emerged, killing more than 5 million people around the globe so far.

The economic impacts of this variant were already being felt. The European Union and the U.K. both announced travel restrictions from southern Africa on Friday. After the market closed, the U.S. also put travel restrictions on those coming from South Africa as well as seven other African nations.

Airline stocks quickly sold off, with United Airlines dropping 9.6% and American Airlines falling 8.8%.

“COVID had seemingly been put in the rear-view mirror by financial markets until recently,” Douglas Porter, chief economist at BMO Capital Markets. “At the least, [the virus] is likely to continue throwing sand in the gears of the global economy in 2022, restraining the recovery [and] keeping kinks in the supply chain.”

Even Bitcoin got caught up in the selling. The digital currency dropped 8.4% to $54,179, according to CoinDesk.

In Nantucket, Massachusetts, where he is spending a holiday weekend, President Joe Biden said he wasn’t concerned about the market’s decline.

“They always do when there’s something on COVID [that] arises,” Biden said.

‘Fear gauge’

One sign of Wall Street’s anxiety was the VIX, the market’s measurement of volatility that is sometimes referred to as its “fear gauge.” The VIX jumped 53.6% to a reading of 28.54, its highest reading since January, before the vaccines began to be widely distributed.

Fearful of more lockdowns and travel bans, investors moved money into companies that largely benefited from previous waves, like Zoom Communications for meetings or Peloton for at-home exercise equipment. Shares in both companies rose nearly 6%.

The coronavirus vaccine manufacturers were among the biggest beneficiaries of the emergence of this new variant and the subsequent investor reaction. Pfizer shares rose more than 6% while Moderna shares jumped more than 20%.

Merck shares fell 3.8%, however. While U.S. health officials said Merck’s experimental treatment of COVID-19 was effective, data showed the pill was not as effective at keeping patients out of the hospital as originally thought.

Investors are worried that the supply chain issues that have impacted global markets for months will worsen. Ports and freight yards are vulnerable and could be shut by new, localized outbreaks.

Source: Voice of America

November 29, 2021

Chery’s Export Sales Exceed 200,000, Breaking Record for Chinese Brands

BAGHDAD, Nov. 29, 2021 /PRNewswire/ — Recently, Chery Group released its latest sales data. Against the complicated environments such as the changes in the pandemic situation and global chip shortages in the car industry, Chery continued to maintain the fastest growth rate in China’s automotive industry, achieving cumulative sales of 739,730 vehicles from January to October, up 44.3% year over year.

Tiggo 7 Pro has become the most popular Chinese SUV in Russia

As for exports, in October, Chery exported more than 20,000 vehicles for the sixth time this year with total sales of 25,049 vehicles, an increase of 92.7% year-over-year. From January to October, the cumulative sales volume was 212,959 vehicles, up 145.7% year-over-year. While setting a new historical record, Chery firmly maintained its leading position in export among all Chinese passenger vehicles.

In the Russian market, which Chery has been cultivating for 16 years, Chery has always been the “people’s vehicle” in the eyes of local people. According to the data released by AEB (Association of European Business), Chery’s cumulative sales from January to October increased by 266% year-over-year, ranking first among all automobile brands, and Tiggo 7 became the most popular Chinese SUV model in Russia in October.

In Chile, according to the data released by ANAC (Asociación Nacional Automotive Riz de Chile A.G.), Chery ranked fourth among all automobile brands in October, surpassing brands such as Toyota, Kia, and Volkswagen, with a year-over-year growth of 101.4% and a market share of 6.3%. In the SUV market segment, the sales market share reached 15.3% in October, ranking first for ten consecutive months, and Tiggo 2 series became the best-selling SUV model.

According to the data released by Fenabrave (National Federation of Automotive Vehicles Distribution) of Brazil, Chery’s sales in October increased by 127% year-over-year, surpassing Nissan to take ninth place in passenger vehicle sales, ranking among the top ten in sales for six consecutive months and reaching a record-breaking market share of 3.97%. In the SUV market segment, Tiggo 8, Tiggo 3X (Tiggo 2 Pro in other markets) and other models continued to sell well.

The cumulative sales exceeding 200,000 in the first ten months not only meant that Chery completed the annual export target of 200,000 vehicles ahead of schedule, but also made Chery the first Chinese passenger vehicle manufacturer to export more than 200,000 vehicles annually. Chery, which has been “sailing abroad” for 20 years, has become a business card for Chinese automobile brands to go global. Up to now, Chery has accumulated 9.8 million global users, including 1.9 million overseas users. Chery is about to turn over a new leaf.

About Chery

Chery is a Chinese automobile brand with global influence. Chery has established a research and development team of more than 5,500 people through five global research and development bases, and has the most powerful research and development strength of engine, transmission, chassis, and other core technologies among Chinese automobile brands. Chery is also the first Chinese automobile company to export vehicles, CKD parts, engines and vehicle manufacturing technology and equipment to the world. Up to now, Chery has exported its vehicles to more than 80 countries and regions, and has set up 10 overseas factories, more than 1,500 overseas dealerships and service outlets, with nearly 9.8 million users worldwide, ranking first in the number of passenger cars exported from China for 18 consecutive years.

For more information, please send an email to cheryiraq@mychery.com

FACEBOOK: CHERY IQ
INSTAGRAM: chery_iq

Photo – https://mma.prnewswire.com/media/1697698/Tiggo_7_Pro_popular_Chinese_SUV_Russia.jpg
Photo – https://mma.prnewswire.com/media/1697699/Chery_User_Event_Chile.jpg
Photo – https://mma.prnewswire.com/media/1697697/Arrizo_6_Pro_sells_Brazil.jpg

November 29, 2021

imo Ads Highlights 5 Mobile Marketing Trends for 2022 Ahead of Brainscape 2021

DUBAI, UAE, Nov. 29, 2021 /PRNewswire/ — imo Ads, a global mobile marketing platform that provides comprehensive branding and performance solutions for businesses located in the MENA region, will participate in the 11th annual BrainScape, one of the largest marketing conferences in the region. imo Ads will have its own virtual booth where it will welcome business, marketing and communications professionals from all over the world to showcase the value of its platform and demonstrate how they can prepare to attract customers on current and emerging digital platforms.

“BrainScape is a conference designed to explore how new thinking and a fresh approach can help companies and brands reach higher levels of success”, said Joanna Zhao, Head of Ad Sales, imo Ads. “The marketing and communications landscape is constantly evolving with relatively new and emerging technologies such as Artificial Intelligence (AI), Machine Learning, Livestreaming, the Metaverse and more. In order for companies to stay both competitive and relevant they need to become more agile not only with the technology they use, but how they plan to incorporate marketing strategies and tactics across every customer touch-point both online and offline.”

imo Ads leverages its premium resources to provide highly targeted and customized marketing solutions to help brands achieve stronger exposure, and reach users more effectively. With significant data resources and powerful algorithm capabilities, imo Ads could assist brands in maximizing their own potential and ROI through precise reach and efficient conversion.

A recent report states that people in the MENA region spend a lot of time on social media, averaging about 3.5 hours a day, across platforms. If we take a closer look at UAE, mobile phones remains the preferred device of choice as it accounts for 60.5 percent of web traffic across devices, according to Global Media Insight

With mobile and social platforms visibly being the future of marketing and communicating with potential customers, ahead of the conference, imo Ads shares a few trends that will be relevant to marketers in 2022.

Video will continue to be important

Video content is quite engaging and attention grabbing. In fact, people pay more attention to video than to any other types of content, which is why watching short videos or live posts or stories as well as sharing videos on instant messaging apps are amongst the top 3 most regular uses of the phone across the Middle East region, according to Deloitte Global Mobile Consumer Survey, Middle East Edition 2019.

As a result, mobile markets will need to utilize video advertising utilizing some best practices to ensure that their messages and promotions stay relevant. These best practices include: starting strong, keeping it short and staying relevant to your target audience.

In order to deliver successful video ads, the right platform is required. Social media plays a vital role in terms of both boosting video content and enhancing reach and a good mix of cross-platform advertising is essential.

Businesses, regardless of their size, should all focus their efforts to invest in creative production to maximize the impact they will have in the near future.

Personalization is key

In just one day, mobile users are exposed to hundreds of mobile ads through their smart phones, which is why brands need to go beyond creativity to create messages that really speak to the users. In fact, personalization can reduce acquisition costs by as much as 50 percent, lift revenues by 5 percent to 15 percent, and increase the efficiency of marketing spend by up to 30 percent.

To create ads that are more personalized, marketers would need to leverage data. This is because through user data and behavior, marketers can learn a lot about what their customers prefer such as what kind of visuals, messages or CTAs they would want to see.

In addition to data analytics, marketers can utilize user feedback to create more personalized experience. Regardless of the source, be it from reviews, customer service issues, discussions at various touch points and more, marketers should listen to drive better user engagement and mobile user experience.

AI rises to prominence

Gathering intelligence from a variety of sources will prove to be quite a challenge for marketing professionals. However new technologies are continuing to emerge and evolve to generate more insights to help marketers create more content that is both meaningful and impactful.

One of these technologies is Artificial Intelligence (AI), which will become essential as brands dive deeper into mobile marketing in the forthcoming years. Businesses have been using AI such as image recognition, dynamic pricing, sales forecasting and more to create offerings that are personalized to potential customer segments.

Therefore, in 2022, we can expect to see an increase in marketing spend on AI technologies to create a more holistic customer experience across a variety of platforms both online and offline.

Mobile-First & Commerce Marketing

People are and will continue to spend more time on their smartphones as mobile applications become more versatile. imo for example, used to be an instant messaging application between single users has evolved over the years to include more features such as: Big Group Chats; short ‘Story’ updates; share files of up to 10GB and even participate in Chatrooms where users can match people from different places in the same country expanding their own reach and giving them the opportunity to make friends with similar interests.

As a result, it is imperative for businesses to create mobile-friendly content that users will not only appreciate but will also rank higher across search engines. A simple strategy could be as simple as adapting the design of a website to fit screens of smartphones or tablets.

We are living in the age of the “Everything Customer”. These people are individuals who are not brand loyal but are sensitive to both the price and the overall experience. A responsive design for a website or mobile application is just one necessity to provide ease of access and convenience when browsing or shopping.

Furthermore, mobile commerce will continue to witness exponential growth going into 2022 as more consumers are using their smartphones to shop online. In fact, many marketing experts believe that mobile commerce will play a pivotal role in marketing in 2022.

Any brand that seeks to capture the mobile-first customer should have an app that is not only simple and easy to navigate, but provides exceptional customer experience. What will accelerate the growth of mobile commerce is social commerce through various social media platforms and even livestreaming applications. Mobile commerce is still at an early stage, however as potential customers get comfortable with exploring social commerce, brands will be motivated to focus their strategies and tactics accordingly to tap into their ever evolving and growing customer base.

Optimizing for Voice

Many prominent organizations from around the world such as Google, Amazon and Apple continue to invest in audio development with voice search playing a key role. Voice Assistants are improving almost every day and making our lives easier as we are now able to control a plethora of smart gadgets and appliances in our homes simply with our voice.

The potential of voice commands for marketers is simply infinite due to its level of convenience as it relates to searching for and purchasing items. As a result, for the coming year and the foreseeable future, businesses will need to rethink their online marketing approach due to the increase in popularity of voice search.

The 11^th edition of BrainScape is set to take place on 29 November 2022 at La Perle, Al Habtoor City, Dubai, UAE. For more information please visit: phdbrainscape.com.

To learn more about imo ads, please contact: imoads@imo.im.

Photo – https://mma.prnewswire.com/media/1696909/image_849502_26156503.jpg
Photo – https://mma.prnewswire.com/media/1696908/imo_Ads.jpg

November 29, 2021

‫تتويج شركة جي في جي “شركة التكنولوجيا للعام” في أسبوع التكنولوجيا الأفريقي

كيب تاون، جنوب أفريقيا, 29 نوفمبر / تشرين ثاني 2021 /PRNewswire/ — تم تتويج شركة غلوبال فويس غروب (جي في جي)، ، وهي شركة مزودة رائدة لتقنيات قوانين وأنظمة الامتثال وحلول البيانات للحكومات والوكالات الولائية، “شركة التقنية للعام” من قبل أسبوع التقنية الأفريقي، وذلك في حفل توزيع جوائز أقيم في جنوب أفريقيا يوم 24 تشرين الثاني/نوفمبر. وقد تنافست المئات من الشركات الأخرى في فئات مختلفة، بما في ذلك ثمانية لاعبين رئيسيين في الصناعة تم ترشيحهم إلى جانب جي في جي للحصول على نفس الجائزة المرموقة.

كانت هذه هي النسخة السنوية الثالثة من هذا الحدث الأفريقي الذي يركز على توعية البلدان الأفريقية بالتحديات والفرص التي يمكن اكتسابها من خلال صياغة الخطط والسياسات المناسبة لدفعها إلى الثورة الرقمية والتكنولوجية. في كل عام، تقوم لجنة التحكيم المستقلة في أسبوع التقنية الأفريقي بتقييم مئات المرشحين لمكافأة أولئك الذين تميزوا أكثر في هذا المجال.

ولدى قبوله الجائزة بفخر نيابة عن الشركة، انتهز مدير التكنولوجيا في جي في جي، لوران سار، الفرصة للتأكيد على الأهمية القصوى لتكنولوجيا المعلومات والاتصالات للبلدان الأفريقية، “في غلوبال فويس غروب،“كما قال ““نحن نؤمن حقًا بتنمية إفريقيا من خلال تكنولوجيا المعلومات والاتصالات. وهذا هو سبب ابتكارنا دائمًا لتقديم حلول رقمية للحكومات و (…) المؤسسات لمساعدتها [في رقمنة] عملياتها و [تعزيز] التنمية من خلال تكنولوجيا المعلومات والاتصالات.”“

قبل فترة طويلة من انتشار الوباء الذي سلط الضوء على ضرورة تسريع التحول الرقمي في البلدان الناشئة، من بين الاحتياجات الملحة الأخرى، اعتمدت معظم الحكومات الأفريقية بالفعل أجنداتها الرقمية الخاصة. يسمح لنا حدث مثل أسبوع التكنولوجيا الأفريقي بتقدير التقدم المحرز في هذا الصدد وتسليط الضوء على مساهمة المنظمات العامة والخاصة مثل جي في جي في تطوير مجتمعات رقمية ديناميكية وشاملة ومرنة في إفريقيا.

نبذة عن مجموعة غلوبال فويس غروب (جي في جي) تأسست المجموعة عام 1998، وتنتشر أفرعها في 11 دولة، وتُعد جلوبال فويس إحدى الشركات العالمية المهتمة بتقديم حلول تكنولوجيا المعلومات والاتصالات والتكنولوجيا التنظيمية للهيئات الحكومية والجهات التنظيمية. تدعم مجموعة غلوبال فويس جهود الجهات الحكومية والهيئات الأخرى نحو التحول الرقمي، وذلك من خلال تحليلات البيانات الضخمة، كما تساعد المجموعة هذه الهيئات في الترويج الفعال لبيئات الأنظمة الرقمية المبسطة والتي تتسم بشمول مالي حقيقي. تعمل الشركة على رصد بيانات القطاعات الاقتصادية المحورية وجمعها وتحليلها بهدف تحويلها إلى معلومات ذات قيمة عملية. ندعم عمليات اتخاذ القرار القائمة على البيانات.

يمكنكم زيارة موقع الشركة الإلكتروني عبر هذا الرابط : www.globalvoicegroup.com

الشعار – https://mma.prnewswire.com/media/996162/GVG_Logo.jpg